To investigate the intrinsic roles of CD73 in CRC cell lines, by using CRISPR/Cas9 (sgNT5E) technology, we first generated CD73-deficient CRC cell lines (Fig. S2) then tested the proliferative abilities of control and CD73-deficient cell lines by cell viability assay. This evidence concerns the gene NT5E and colorectal carcinoma.